PLSE Pulse Biosciences, Inc
$53.11▼ -2.43%
Healthcare
Other
After hours
$52.11▼ -1.88%
Sep 11, 7:30 PM ET
Volume 664.3K
Avg Volume (10D) 775.4K
Key Metrics & Fundamentals
Market Cap
$3.79B
P/E Ratio
–
Div Yield
–%
52W Range
12.56 - 58.90
% vs 50 MA
38.23%
% vs 200 MA
120.67%
RSI-14
66.7
MACD Histogram
-0.2000
Beta (1Y vs SPY)
2.16
Free Cash Flow
-$18.80M
Gross Rev
$434,000
Gross Profit
$161,000
EBITDA
-$25.02M
COGS
$273,000
Operating Exp
$25.43M
Operating Income
-$25.27M
EBIT
-$25.27M
Pretax Income
-$24.66M
Net Income
-$24.66M
EPS (Diluted)
-0.36
Price & Volume History
Loading chart…
Recent News

Why Pulse Biosciences Stock Popped Today
Motley Fool · Sep 9, 2026 11:44 PM

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire · Sep 4, 2026 11:00 AM

Pulse Biosciences (PLSE) Stock Looks Pricey On Book Value Yet Strong On Returns
Simply Wall St. · Aug 16, 2026 4:08 PM

Pulse Biosciences Eyes AFib Breakthrough With Nanosecond PFA Platform
MarketBeat · Aug 16, 2026 1:01 PM

Pulse Biosciences (PLSE) Prices A $75 Million Offering, Is The Stock Fully Valued?
Simply Wall St. · Aug 16, 2026 6:10 AM

Pulse Biosciences (PLSE) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 11:31 PM
Sector Update: Healthcare Stocks Rise Late Afternoon
MT Newswires · Aug 7, 2026 7:49 PM
Sector Update: Healthcare
MT Newswires · Aug 7, 2026 7:24 PM
Pulse Biosciences Shares Rise After Q2 Results
MT Newswires · Aug 7, 2026 6:55 PM
Pulse Biosciences, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 7, 2026 12:30 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See PLSE's money flow as a full page
Social Sentiment
Avg -0.80 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.